News articles

News article list

• NICE recommends innovative technology for people with breast cancer

  A magnetic marker liquid injected into people with invasive breast cancer will help surgeons discover if the cancer has spread.

• More than 400 people could benefit from life-extending advanced lung cancer treatment

  Durvalumab recommended as an option for treating non-small-cell lung cancer.

• NICE outlines steps needed to put ME/CFS guideline into practice

  NICE has today, (Thursday, 12 May 2022) published its implementation statement for its recent guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS)

• Healthier lifestyle can help to ease osteoarthritis symptoms says NICE

  Exercise has an important role to play in helping people living with osteoarthritis NICE says in draft updated guidelines published today (29th April 2022).

• Over 700 people a year could benefit from a new lung cancer drug

  An innovative and potentially life-extending drug for treating people with a specific gene mutation of advanced non-small-cell lung cancer (NSCLC) has been recommended by NICE and will be available to patients from today (Thursday, 14 April).

• NICE reaches important milestone in the UK’s efforts to tackle antimicrobial resistance.

  Two new antimicrobial drugs are close to becoming the first to be made available as part of the UK’s innovative subscription-style payment model.